Study ID | Study follow‐up (months) | FINLAY‐FR‐2 (n) | Placebo (n) | Important outcomes | ||
GMT of specific antibody against 2019 novel coronavirus | GMT of neutralizing antibody against 2019 novel coronavirus | Local reactogenicity events | ||||
Toledo‐Romani 2021 (RPCEC00000354) | 5.2 | 14,679 | 14,675 | X | X | * |